Cardiopediatric Home Monitoring Tool

Launched by NANTES UNIVERSITY HOSPITAL · Dec 16, 2024

Keywords

ClinConnect Summary

The Cardiopediatric Home Monitoring Tool trial is studying whether a special home monitoring program can help children with congenital heart defects recover better after heart surgery. Researchers believe that by using technology like sensors to track health at home and having a team ready to respond to any alerts, this program can lower the chances of complications and improve survival rates.

To be eligible for this trial, children must be between 0 and 36 months old, have undergone heart surgery at Nantes University Hospital, and have parental consent. They must also be able to go home safely after surgery. Participants can expect to use a home monitoring tool that keeps track of their health and sends alerts if anything unusual happens. This innovative approach aims to make recovery easier and safer for young patients and their families.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients aged between 0 and 36 months inclusive
• • With a congenital heart defect
• • Underwent cardiac surgery at Nantes University Hospital
• • Affiliated to a social security scheme
• • Free, informed and written consent of the 2 holders of parental authority
• Non Inclusion Criteria:
• • Clinical or family situation contraindicating a return home
• • Physical inability to connect to the Exolis platform at home
• • Insufficient understanding on the part of those with parental authority
• • Extracardiac co-morbidities responsible for organ failure requiring repeated
• • Hospitalisation for non-cardiovascular reasons (e.g. severe renal failure, neurological neurological deficit, complex immune deficiency, etc).
• • Patient and/or parents under legal protection